Clinical Trials Browser

Phase 1/2 × entrectinib × Dermatologic × Clear all

NCT04589832 2023-11-22

Study of PAC-1 and Entrectinib for Patients With Metastatic Uveal Melanoma

Phase 1/2 Terminated

6 enrolled 9 charts

Uveal Melanoma